Staff Reports
In a fiery move that could ruffle feathers, Republican Arizona Rep. Paul Gosar is not holding back in his recent crusade against the medical device company TransMedics. Gosar penned a scathing letter to the CEO of TransMedics, demanding answers as to why their lifesaving technology seems to be held captive by skyrocketing costs and shady business practices. The Daily Caller got the scoop on Gosar’s letter, and boy, is it a doozy!
Gosar shines a light on TransMedics’ questionable behavior, pointing out how they started jacking up prices on their Organ Care System (OCS) post-FDA approval in 2021. What was once a semi-affordable $30,000 buy-in for transplant centers suddenly turned into a jaw-dropping $60,000 PER disposable cassette. Talk about a price hike that could make your wallet faint! The congressman called out TransMedics’ sneaky move of making themselves the sole bosses of the OCS, forcing transplant centers to lease the device and pay an extra $20,000 for surgical recovery. Sounds like a heist in broad daylight!
🚨EXCLUSIVE🚨Rep. Gosar Accuses TransMedics Of Holding Lifesaving Medical Devices ‘Hostage’ — Vows Oversight from @henryrodgersdc https://t.co/dBNv17ZFKn
— Daily Caller (@DailyCaller) February 22, 2024
Adding insult to injury, Gosar raises an eyebrow at TransMedics’ alleged lavish use of private aircraft for staff transport without any real urgency involved. He questions if these fancy flights are just a CEO’s version of a joyride on the company dime. Gosar even throws shade at TransMedics for pressuring hospitals to use their outrageously expensive aircraft, even if it means doubling or tripling the transportation costs. It’s like a high-flying extortion scheme, but with vital organs on the line!
With a no-nonsense tone, Gosar demands answers to his hard-hitting questions by February 26th, 2024. He labels TransMedics as a profit-hungry corporation losing sight of its original mission to save lives. The House GOP leadership aide, echoing Gosar’s sentiments, paints TransMedics as a villain playing with taxpayer money and hampering critical medical care for the sake of a quick buck. It’s a slap in the face to patients waiting for transplants and an unwelcome reminder of corporate greed gone wild.
If Gosar’s call for transparency and accountability isn’t answered, there might just be some Capitol Hill fireworks ahead. Congress could swoop in to investigate TransMedics’ practices, shining a harsh spotlight on their alleged anticompetitive antics and holding medical progress hostage for the sake of profit margins. Let’s hope TransMedics is ready to face the music and prove they’re not just a medical marvel turned money-hungry machine. Tick tock, TransMedics, the conservative crusaders are watching!
